6.
Chen H, Li L, Hu J, Zhao Z, Ji L, Cheng C
. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. J Exp Clin Cancer Res. 2019; 38(1):297.
PMC: 6617940.
DOI: 10.1186/s13046-019-1278-9.
View
7.
Li Y, Wei J, Sun Y, Zhou W, Ma X, Guo J
. Regulates the Proliferation, Migration, Invasion, and Cell Cycle of Breast Cancer Cells via the JAK2/STAT3 Signaling Axis. Int J Mol Sci. 2023; 24(21).
PMC: 10647495.
DOI: 10.3390/ijms242115819.
View
8.
Liu J, Zhu Y, Wang H, Han C, Wang Y, Tang R
. LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer Sci. 2024; 115(3):804-819.
PMC: 10920983.
DOI: 10.1111/cas.16049.
View
9.
Vahitha V, Lali G, Prasad S, Karuppiah P, Karunakaran G, Alsalhi M
. Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions. Mol Biol Rep. 2024; 51(1):61.
DOI: 10.1007/s11033-023-09032-w.
View
10.
Lorusso G, Ruegg C
. New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol. 2012; 22(3):226-33.
DOI: 10.1016/j.semcancer.2012.03.007.
View
11.
Wang Y, Ning H, Ren F, Zhang Y, Rong Y, Wang Y
. GdX/UBL4A specifically stabilizes the TC45/STAT3 association and promotes dephosphorylation of STAT3 to repress tumorigenesis. Mol Cell. 2014; 53(5):752-65.
DOI: 10.1016/j.molcel.2014.01.020.
View
12.
Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A
. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021; 13(17).
PMC: 8428369.
DOI: 10.3390/cancers13174287.
View
13.
Krenciute G, Liu S, Yucer N, Shi Y, Ortiz P, Liu Q
. Nuclear BAG6-UBL4A-GET4 complex mediates DNA damage signaling and cell death. J Biol Chem. 2013; 288(28):20547-57.
PMC: 3711319.
DOI: 10.1074/jbc.M112.443416.
View
14.
Kashyap D, Pal D, Sharma R, Garg V, Goel N, Koundal D
. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. Biomed Res Int. 2022; 2022:9605439.
PMC: 9038417.
DOI: 10.1155/2022/9605439.
View
15.
Zhang J, Li R, Dong X, He N, Yin R, Yang M
. Design, Synthesis and Structure-Activity Relationship Studies of Meridianin Derivatives as Novel JAK/STAT3 Signaling Inhibitors. Int J Mol Sci. 2022; 23(4).
PMC: 8875316.
DOI: 10.3390/ijms23042199.
View
16.
Liang J, Li J, Fu Y, Ren F, Xu J, Zhou M
. GdX/UBL4A null mice exhibit mild kyphosis and scoliosis accompanied by dysregulation of osteoblastogenesis and chondrogenesis. Cell Biochem Funct. 2018; 36(3):129-136.
DOI: 10.1002/cbf.3324.
View
17.
Fu Y, Liu S, Wang Y, Ren F, Fan X, Liang J
. GdX/UBL4A-knockout mice resist collagen-induced arthritis by balancing the population of T1/T17 and regulatory T cells. FASEB J. 2019; 33(7):8375-8385.
DOI: 10.1096/fj.201802217RR.
View
18.
Bodac A, Mayet A, Rana S, Pascual J, Bowler A, Roh V
. Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth. EMBO Mol Med. 2024; 16(1):158-184.
PMC: 10897164.
DOI: 10.1038/s44321-023-00013-x.
View
19.
Zhou X, Zhao J, Yan T, Ye D, Wang Y, Zhou B
. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway. Cell Death Dis. 2024; 15(4):260.
PMC: 11014919.
DOI: 10.1038/s41419-024-06643-4.
View
20.
Wen X, Hou Y, Zhou L, Fang X
. LINC00969 inhibits proliferation with metastasis of breast cancer by regulating phosphorylation of PI3K/AKT and ILP2 expression through HOXD8. PeerJ. 2023; 11:e16679.
PMC: 10734406.
DOI: 10.7717/peerj.16679.
View